Literature DB >> 17117419

Topographical organization of GABAergic neurons within the ventral tegmental area of the rat.

Valerie G Olson1, Eric J Nestler.   

Abstract

The ventral tegmental area (VTA), the origin of dopaminergic cell bodies that comprise the mesocorticolimibic DA system, is widely implicated in drug and natural reward, cognition, and several psychiatric disorders. In addition to dopaminergic neurons, this region is populated by GABAergic neurons, which both regulate the firing of their dopaminergic counterparts and send projections throughout the brain. Although the dopaminergic neurons of the VTA have been extensively characterized neuroanatomically, much less is known about the GABAergic neurons in this region. Recent data suggest that the rostro-caudal topographic organization of these GABAergic neurons may correspond to their ability to regulate drug reward. In the present study, we used immunohistochemical techniques to examine the frequency and topography of GABAergic neurons throughout the rostro-caudal axis of the VTA and the extent to which they coexpress other proteins, including tyrosine hydroxylase (a marker of DA neurons), cholecystokinin, parvalbumin, calretinin, and calbindin d 28k. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17117419     DOI: 10.1002/syn.20345

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  66 in total

1.  The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system.

Authors:  Heather N Lavezzi; Daniel S Zahm
Journal:  Basal Ganglia       Date:  2011-11

2.  Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates.

Authors:  Simon Hong; Thomas C Jhou; Mitchell Smith; Kadharbatcha S Saleem; Okihide Hikosaka
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

3.  Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels.

Authors:  Scott C Steffensen; Seth R Taylor; Malia L Horton; Elise N Barber; Laura T Lyle; Sarah H Stobbs; David W Allison
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

Review 4.  Functional implications of glutamatergic projections to the ventral tegmental area.

Authors:  Stefanie Geisler; Roy A Wise
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

5.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

6.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

Review 7.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

8.  Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.

Authors:  Diane A Lane; Andree A Lessard; June Chan; Eric E O Colago; Yan Zhou; Stefan D Schlussman; Mary Jeanne Kreek; Virginia M Pickel
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

9.  Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Roland Bell; Susan R Sesack
Journal:  Eur J Neurosci       Date:  2009-09-29       Impact factor: 3.386

10.  Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine.

Authors:  Sergio D Iñiguez; Brandon L Warren; Rachael L Neve; Eric J Nestler; Scott J Russo; Carlos A Bolaños-Guzmán
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.